BackNemaura Medical Overview

Nemaura Medical Other Current Liabilities

Latest other current liabilities for NMRD: $1.8M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$1.82M
23.81% YoYΔ $349203.00 vs prior year quarter

Peer average

Loading

Nemaura Medical Other Current Liabilities History

Loading

Nemaura Medical vs. peers: Other Current Liabilities Comparison

Loading

Nemaura Medical Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Nemaura Medical (NMRD) FAQ

Nemaura Medical's other current liabilities stands at $1.8M as of December 2023. That compares with $1.5M in the prior-year period — up 23.8% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Nemaura Medical reported $1.8M in other current liabilities versus $1.5M a year earlier — a 23.8% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $1.5M in the prior-year period — up 23.8% year over year. Sustained growth in other current liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Nemaura Medical's other current liabilities evolved across reporting periods, while the comparison chart places NMRD next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, other current liabilities is commonly used to spot outliers. Nemaura Medical's reading of $1.8M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.